By Ryan Davis ( December 19, 2014, 7:57 PM EST) -- A federal judge has allowed Mylan Pharmaceuticals Inc. to file an interlocutory appeal to the Federal Circuit of his decision that the company is subject to jurisdiction in Delaware in a suit over generic versions of AstraZeneca AB drugs, saying the case raises a novel issue in Hatch-Waxman law....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.